Oramed Pharmaceuticals Inc.
ORMP· Nasdaq
ORMPOramed Pharmaceuticals Inc.
Filed Apr 3, 2015 · 10-Q · 34 days after period end · 0001178913-15-001193
| Metric | Q2 2015 | Q2 2014 | Q2 2013 | Q2 2012 |
|---|---|---|---|---|
| Net Income | -$1.64M | -$1.12M | -$1.23M | -$985.38K |
| EPS Diluted | $0.15 | $0.12 | -$0.17 | $0.17 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oramed Pharmaceuticals Inc. · CIK 1176309 · Engraved from SEC EDGAR
ended Feb 28, 2015 · filed Apr 3, 2015 · 34 d after period end
